Comparing Norplant and Depo-Provera.
In a study done in Singapore in 1988, 100 present and past users of Norplant and 100 present and past users of Depo Provera (an injectable progestin given every three months that thickens cervical mucus and often suppresses ovulation) were questioned about these methods of birth control. 69% of current Norplant users said they would continue using it, while only 31% of current DP users wanted to continue. 60% of current DP users said they intended to switch to Norplant in the future for the convenience; none of the Norplant users wanted to switch.
The most important disadvantage of both methods was reported to be increased menstrual spotting and bleeding. 56% of past users of Norplant said they intended to use the implant again in the future, while only 20% of DP users would do so again--and 56% of them intended to consider Norplant.
The researchers concluded that women favored Norplant over Depo Provera, mainly because of its longer duration of action.
--Reported in Women's Global Network for Reproductive Rights Newsletter #31, Oct-Dec 1989, p.48.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||contraceptive implant vs. injectable progestin|
|Article Type:||Product/Service Evaluation|
|Date:||Jun 22, 1991|
|Previous Article:||Norplant: satisfaction and side-effects.|
|Next Article:||"Female condom" being tested.|